Total Payments
$2,236
2024 Payments
$114.93
Companies
21
Transactions
104
Medicare Patients
8,679
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$2,228 (99.6%)
Education$7.95 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,228 | 103 | 99.6% |
| Education | $7.95 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $635.61 | 31 | $0 (2023) |
| Edwards Lifesciences Corporation | $454.50 | 15 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $290.22 | 16 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $152.33 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $146.36 | 6 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $87.31 | 5 | $0 (2022) |
| Kiniksa Pharmaceuticals International, plc | $71.62 | 3 | $0 (2024) |
| PFIZER INC. | $52.82 | 3 | $0 (2021) |
| Medtronic, Inc. | $50.04 | 1 | $0 (2023) |
| Novo Nordisk Inc | $46.63 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114.93 | 5 | Kiniksa Pharmaceuticals International, plc ($47.01) |
| 2023 | $234.99 | 8 | Edwards Lifesciences Corporation ($88.03) |
| 2022 | $343.37 | 17 | Edwards Lifesciences Corporation ($82.85) |
| 2021 | $395.38 | 18 | Janssen Pharmaceuticals, Inc ($134.02) |
| 2020 | $325.36 | 18 | Novartis Pharmaceuticals Corporation ($111.37) |
| 2019 | $294.73 | 14 | Edwards Lifesciences Corporation ($97.19) |
| 2018 | $249.76 | 13 | Novartis Pharmaceuticals Corporation ($86.98) |
| 2017 | $276.98 | 11 | Novartis Pharmaceuticals Corporation ($230.36) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardiology | ||||||
| 08/29/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Not Applicable | ||||||
| 03/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Not Applicable | ||||||
| 11/02/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| Category: Not Applicable | ||||||
| 09/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/27/2023 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Transcatheter Heart Valves | ||||||
| 06/28/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/27/2023 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Transcatheter Heart Valves | ||||||
| 04/21/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $50.04 | General |
| Category: Transcatheter Valve Systems | ||||||
| 01/13/2023 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/30/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/13/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/06/2022 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: DIABETES | ||||||
| 09/15/2022 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: LUX-Dx_CRM | ||||||
| 09/08/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $30.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: Cardiovascular | ||||||
| 08/09/2022 | Boston Scientific Corporation | LATITUDE Communicator Power Supply (Device) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: LATITUDE_CRM | ||||||
| 06/30/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/02/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Cardiovascular | ||||||
| 05/04/2022 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Transcatheter Heart Valves | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,019 | 4,188 | $1.4M | $365,469 |
| 2022 | 18 | 2,181 | 4,312 | $1.4M | $393,773 |
| 2021 | 18 | 2,221 | 4,410 | $1.4M | $398,835 |
| 2020 | 19 | 2,258 | 4,618 | $1.4M | $386,020 |
Total Patients
8,679
Total Services
17,528
Medicare Billing
$1.5M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 369 | 1,423 | $176,280 | $99,026 | 56.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 203 | 219 | $259,515 | $73,462 | 28.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 221 | 268 | $257,280 | $44,104 | 17.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 203 | 876 | $245,262 | $37,999 | 15.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 203 | 438 | $109,500 | $33,382 | 30.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 128 | 132 | $109,560 | $25,762 | 23.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 139 | 139 | $97,717 | $23,655 | 24.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 203 | 219 | $90,009 | $11,828 | 13.1% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 128 | 132 | $31,680 | $6,014 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $9,900 | $4,139 | 41.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 127 | 131 | $31,440 | $2,840 | 9.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 13 | 24 | $3,600 | $1,706 | 47.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 50 | $1,750 | $956.34 | 54.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 16 | 85 | $1,275 | $357.00 | 28.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 19 | $1,520 | $238.07 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 393 | 1,403 | $169,795 | $99,379 | 58.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 199 | 212 | $251,220 | $74,889 | 29.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 221 | 248 | $238,080 | $43,857 | 18.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 199 | 845 | $237,423 | $40,974 | 17.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 198 | 420 | $105,000 | $36,787 | 35.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 137 | 138 | $114,540 | $28,452 | 24.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 146 | 146 | $102,638 | $24,349 | 23.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 198 | 211 | $86,721 | $11,682 | 13.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 84 | $11,088 | $7,214 | 65.1% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2022 | 137 | 138 | $33,120 | $6,541 | 19.8% |
About Dr. Gary Mo, MD
Dr. Gary Mo, MD is a Cardiovascular Disease healthcare provider based in Camarillo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366550576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Mo, MD has received a total of $2,236 in payments from pharmaceutical and medical device companies, with $114.93 received in 2024. These payments were reported across 104 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,228).
As a Medicare-enrolled provider, Mo has provided services to 8,679 Medicare beneficiaries, totaling 17,528 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Camarillo, CA
- Active Since 08/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1366550576
Products in Payments
- ENTRESTO (Drug) $610.89
- LifeVest (Device) $290.22
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $217.44
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $180.37
- XARELTO (Drug) $152.33
- ELIQUIS (Drug) $140.13
- JARDIANCE (Drug) $114.19
- Arcalyst (Drug) $71.62
- SAPIEN 3 Ultra RESILIA (Device) $56.69
- COREVALVE EVOLUT R (Device) $50.04
- Livalo (Drug) $39.87
- PRADAXA (Drug) $32.17
- Impella (Device) $25.35
- LEQVIO (Drug) $24.72
- SAMSCA (Drug) $24.67
- Adempas (Drug) $24.32
- Rybelsus (Drug) $24.20
- Ozempic (Drug) $22.43
- Repatha (Biological) $20.14
- Reveal LINQ (Device) $17.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.